Long‐term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study

E-ISSN： 1552-4604|55|10|1131-1136

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.10, 2015-10, pp. : 1131-1136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term safety and tolerability of ezetimibe coadministered with simvastatin in hypercholesterolemic patients: a randomized, 12-month double-blind extension study

By Strony John Yang Bo Hanson Mary E. Veltri Enrico P.

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3149-3157

Informa Healthcare

Access to resources Recommend Favorite

Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability

By Montgomery Stuart Emir Birol Haswell Hannah Prieto Rita

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1223-1230

Informa Healthcare

Access to resources Recommend Favorite

Thalamic Stimulation in Patients with Multiple Sclerosis: Long-Term Follow-Up

Stereotactic and Functional Neurosurgery, Vol. 80, Iss. 1-4, 2004-01 ,pp. : 48-55

Karger

Access to resources Recommend Favorite

Long‐term epidemiology of multiple sclerosis in the Northern Seville District

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 2, 2015-08 ,pp. : 111-117

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term evolution of multiple sclerosis disability in the treatment era

ANNALS OF NEUROLOGY, Vol. 80, Iss. 4, 2016-10 ,pp. : 499-510

John Wiley & Sons Inc

Access to resources Recommend Favorite